Skip to content
WATSONWATSONWATSON075075075

Drawing based on the label description. No photo yet.

“Ferrous fumarate tablets are available as round brown tablets debossed with WATSON 075 on one side and plain on the other side”

WATSON 075 pill

Pill with imprint WATSON 075 is brown, round, 6 mm and has been identified as Norethindrone Acetate and Ethinyl Estradiol and Ferrous Fumarate 75 mg. It is used for birth control. It is supplied by Physicians Total Care, Inc.

Norethindrone Acetate and Ethinyl Estradiol and Ferrous Fumarate 75 mg

Imprint
WATSON 075
Strength
75 mg
Used for
Birth control
Color
Brown
Shape
Round
Size
6 mm
Score
No score line
Form
Tablet
Manufacturer
Physicians Total Care, Inc
Drug class
Progestin hormone
NDC
54868-4744, 52544-630, 54868-4744-0

Source: the official drug label on DailyMed (US National Library of Medicine). Last checked .

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Norethindrone Acetate and Ethinyl Estradiol and Ferrous Fumarate pills and guides

What is Norethindrone Acetate and Ethinyl Estradiol and Ferrous Fumarate used for?

Norethindrone Acetate and Ethinyl Estradiol and Ferrous Fumarate is used for birth control.

Medicine type
Progestin hormone; estrogen hormone
Official uses from the US prescribing label

Xarah Fe is indicated for the prevention of pregnancy in women who elect to use combined oral contraceptives as a method of contraception.

Xarah Fe is indicated for the treatment of moderate acne vulgaris in females, ≥ 15 years of age, who have no known contraindications to combined oral contraceptive therapy, desire oral contraception, have achieved menarche, and are unresponsive to topical anti-acne medications. Xarah Fe should be used for the treatment of acne only if the patient desires a combined oral contraceptive for birth control and plans to stay on it for at least 6 months.

Combined oral contraceptives are highly effective for pregnancy prevention. Table 2 lists the typical accidental pregnancy rates for users of combination oral contraceptives and other methods of contraception. The efficacy of these contraceptive methods, except sterilization, depends upon the reliability with which they are used. Correct and consistent use of methods can result in lower failure rates.

  1. ‡Among couples attempting to avoid pregnancy, the percentage who continue to use a method for 1 year.
  2. * Among typical couples who initiate use of a method (not necessarily for the first time), the percentage who experience an accidental pregnancy during the first year if they do not stop use for any other reason.
  3. †Among couples who initiate use of a method (not necessarily for the first time) and who use it perfectly (both consistently and correctly), the percentage who experience an accidental pregnancy during the first year if they do not stop use for any other reason.
  4. §The percentages becoming pregnant in columns and are based on data from populations where contraception is not used and from women who cease using contraception in order to become pregnant. Among such populations, about 89% become pregnant within one year. This estimate was lowered slightly (to 85%) to represent the percent who would become pregnant within one year among women now relying on reversible methods of contraception if they abandoned contraception altogether.

¶Foams, creams, gels, vaginal suppositories, and vaginal film.

  1. #Þ Cervical mucus (ovulation) method supplemented by calendar in the pre-ovulatory and basal body temperature in the post-ovulatory phases.

ßWith spermicidal cream or jelly.

àWithout spermicides.

  1. èThe treatment schedule is one dose within 72 hours after unprotected intercourse, and a second dose 12 hours after the first dose. The Food and Drug Administration has declared the following brands of combined oral contraceptives to be safe and effective for emergency contraception: Ovral® (1 dose is 2 white pills), Alesse® (1 dose is 5 pink pills), Nordette® or Levlen® (1 dose is 4 light-orange pills), Lo/Ovral® (1 dose is 4 white pills), Triphasil® or Tri-Levlen® (1 dose is 4 yellow pills).
  2. ðHowever, to maintain effective protection against pregnancy, another method of contraception must be used as soon as menstruation resumes, the frequency or duration of breastfeeds is reduced, bottle feeds are introduced, or the baby reaches 6 months of age.

Xarah Fe were evaluated for the treatment of acne vulgaris in two randomized, double-blind, placebo-controlled, multicenter, Phase 3, six (28-day) cycle studies. A total of 296 patients received Xarah Fe and 295 received placebo. Mean age at enrollment for both groups was 24 years. At six months each study demonstrated a statistically significant difference between Xarah Fe and placebo for mean change from baseline in lesion counts (see Table 3 and Figure 2). Each study also demonstrated overall treatment success in the investigator’s global evaluation. Patients with severe androgen excess were not studied.

*Numbers rounded to nearest integer

†Limits for 95% Confidence Interval; not adjusted for baseline differences

Xarah Fe users who started with about 74 acne lesions had about 42 lesions after 6 months of treatment. Placebo users who started with about 72 acne lesions had about 49 lesions after the same duration of treatment.

Figure 2. Mean Percent Reduction in Total Lesion Counts From Baseline to Each 28-Day Cycle and Mean Total Lesion Counts at Each Cycle Following Administration of Xarah Fe and Placebo (Statistically significant differences were not found in both studies individually until cycle 6)

From the FDA-approved label on DailyMed (published Feb 07, 2025).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your pill? Check every detail

  • One side shows WATSON 075 and the other side is plain.
  • It is brown, round, 6 mm.
  • Its score line and coating match the details on this page.
  • It came from a pharmacy package that names the same drug.

Sold under the brand name Microgestin Fe.

One of the pills in the Microgestin Fe pack.

Ingredients

Active: Ferrous Fumarate

Inactive: Sodium Starch Glycolate Type A Corn, Cellulose, Microcrystalline, Magnesium Stearate

Other pills with imprint WATSON 075

Same imprint, different listing. Check the color, size and maker against your pill.

Pills that look similar but are different drugs

Same color and shape, different medicine. This is why the imprint matters.

Other Norethindrone Acetate and Ethinyl Estradiol and Ferrous Fumarate pills